Integrating paroxysmal nocturnal hemoglobinuria (PNH) into mainstream hematological curriculum training
Paroxysmal nocturnal hemoglobinuria (PNH) is an ultra ‐ orphan life ‐ threatening disorder characterized by chronic intravascular hemolysis (IVH) and thrombosis. 1 Prior to eculizumab approval, patients with PNH had a median survival of between 10 and 22 years 2,3 with thrombosis accounting for 22% – 67% of death in ca...